Thrombopoietin receptor agonists for treatment of poor graft function after allogeneic hematopoietic stem cell transplantation in adults

Q4 Medicine

Cellular Therapy and Transplantation Pub Date : 2019-06-28 DOI:10.18620/ctt-1866-8836-2019-8-2-38-44

T. Rudakova, A. Kulagin, I. Moiseev, T. Bykova, S. Bondarenko, M. Barabanshikova, A. Beinarovich, A. Osipova, V. Ovechkina, A. Alyanskiy, E. I. Darskaya, E. Morozova, B. Afanasyev

引用次数: 7

Abstract

Tatiana A. Rudakova, Alexander D. Kulagin, Ivan S. Moiseev, Tatyana A. Bykova, Sergey N. Bondarenko, Maria V. Barabanshikova, Anastasia V. Beinarovich, Anna A. Osipova, Varvara N. Ovechkina, Alexander L. Alyanskiy, Elena I. Darskaya, Elena V. Morozova, Boris V. Afanasyev Raisa Gorbacheva Memorial Research Institute of Pediatric Oncology, Hematology and Transplantation, Chair of Hematology, Transfusiology and Transplantology, Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia Thrombopoietin receptor agonists for treatment of poor graft function after allogeneic hematopoietic stem cell transplantation in adults Cellular Therapy and Transplantation (CTT). Vol. 8, No. 2, 2019 doi: 10.18620/ctt-1866-8836-2019-8-2-38-44 Submitted: 31 July 2019, accepted: 09 August 2019

查看原文本刊更多论文

血小板生成素受体激动剂治疗成人异基因造血干细胞移植后移植物功能差

Tatiana A. Rudakova, Alexander D. Kulagin, Ivan S. Moiseev, Tatyana A. Bykova, Sergey N. Bondarenko, Maria V. Barabanshikova, Anastasia V. Beinarovich, Anna A. Osipova, Varvara N. Ovechkina, Alexander L. Alyanskiy, Elena I. Darskaya, Elena V. Morozova, Boris V. Afanasyev Raisa gorbachev纪念儿科肿瘤学、血液学和移植研究所，巴甫洛夫第一圣彼得堡国立医科大学血液学、输血学和移植学主任，在成人细胞治疗和移植(CTT)中，血小板生成素受体激动剂治疗同种异体造血干细胞移植后移植物功能差。《科学》第8卷第2期，2019年doi: 10.18620/ctt-1866-8836-2019-8-2-38-44提交时间:2019年7月31日，接受时间:2019年8月9日

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cellular Therapy and Transplantation Medicine-Transplantation

CiteScore

0.60

自引率

0.00%

发文量